Perbak Capital Partners LLP Purchases 1,341 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Perbak Capital Partners LLP boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 59.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,578 shares of the company's stock after acquiring an additional 1,341 shares during the period. Perbak Capital Partners LLP's holdings in HCA Healthcare were worth $1,074,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Galvin Gaustad & Stein LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $18,044,000. NRI Wealth Management LC purchased a new stake in shares of HCA Healthcare during the fourth quarter valued at $2,896,000. Czech National Bank lifted its stake in HCA Healthcare by 4.5% during the 4th quarter. Czech National Bank now owns 39,543 shares of the company's stock valued at $11,869,000 after acquiring an additional 1,691 shares during the period. Peak Financial Advisors LLC bought a new stake in shares of HCA Healthcare in the fourth quarter worth approximately $1,122,000. Finally, Wedge Capital Management L L P NC boosted its holdings in HCA Healthcare by 7.7% in the fourth quarter. Wedge Capital Management L L P NC now owns 116,075 shares of the company's stock worth $34,840,000 after purchasing an additional 8,329 shares during the last quarter. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Price Performance

Shares of HCA traded up $5.07 during mid-day trading on Friday, hitting $348.11. 802,331 shares of the stock were exchanged, compared to its average volume of 1,400,124. The firm has a 50-day moving average of $331.79 and a two-hundred day moving average of $330.21. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a market cap of $85.71 billion, a PE ratio of 15.84, a price-to-earnings-growth ratio of 1.10 and a beta of 1.48. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The business's quarterly revenue was up 5.7% on a year-over-year basis. During the same period in the previous year, the firm posted $5.36 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.83%. The ex-dividend date is Monday, June 16th. HCA Healthcare's dividend payout ratio is currently 12.81%.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on HCA. Truist Financial dropped their price target on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating on the stock in a research note on Monday, January 6th. Cantor Fitzgerald restated an "overweight" rating and set a $405.00 target price on shares of HCA Healthcare in a research report on Monday, January 27th. Barclays dropped their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research note on Monday, January 27th. StockNews.com raised HCA Healthcare from a "hold" rating to a "buy" rating in a report on Monday, April 28th. Finally, Baird R W lowered shares of HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has an average rating of "Moderate Buy" and an average target price of $381.13.

Insiders Place Their Bets

In other news, SVP Jennifer Berres sold 9,533 shares of the firm's stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now directly owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.